ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Veeva Systems (NYSE:VEEV) Beats Q4 Sales Targets, Stock Soars

VEEV Cover Image

Healthcare software provider Veeva Systems (NASDAQ: VEEV) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 14.3% year on year to $720.9 million. The company expects next quarter’s revenue to be around $727.5 million, close to analysts’ estimates. Its non-GAAP profit of $1.74 per share was 10.1% above analysts’ consensus estimates.

Is now the time to buy Veeva Systems? Find out by accessing our full research report, it’s free.

Veeva Systems (VEEV) Q4 CY2024 Highlights:

  • Revenue: $720.9 million vs analyst estimates of $699.1 million (14.3% year-on-year growth, 3.1% beat)
  • Adjusted EPS: $1.74 vs analyst estimates of $1.58 (10.1% beat)
  • Adjusted Operating Income: $307.7 million vs analyst estimates of $277.9 million (42.7% margin, 10.7% beat)
  • Management’s revenue guidance for the upcoming financial year 2026 is $3.05 billion at the midpoint, in line with analyst expectations and implying 11% growth (vs 16.5% in FY2025)
  • Management’s operating profit (non-GAAP) guidance for the upcoming financial year 2026 is $1.30 billion at the midpoint, above analyst expectations
  • Operating Margin: 26.1%, up from 21.4% in the same quarter last year
  • Free Cash Flow Margin: 9%, down from 22.9% in the previous quarter
  • Market Capitalization: $35.47 billion

"It was an outstanding quarter and year of execution and innovation in software, data, and business consulting," said CEO Peter Gassner.

Company Overview

Built on top of Salesforce as one of the first vertical-focused cloud platforms, Veeva (NYSE: VEEV) provides data and customer relationship management (CRM) software for organizations in the life sciences industry.

Healthcare And Life Sciences Software

The coronavirus pandemic has underscored the importance of high-quality health infrastructure in times of crisis. Coupled with intense competition between drugmakers and the growing volume of data in the health care sector, demand for data management solutions in the healthcare space is expected to remain strong in the years ahead.

Sales Growth

A company’s long-term performance is an indicator of its overall quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Over the last three years, Veeva Systems grew its sales at a 14.1% annual rate. Although this growth is acceptable on an absolute basis, it fell short of our standards for the software sector, which enjoys a number of secular tailwinds. Luckily, there are other things to like about Veeva Systems.

Veeva Systems Quarterly Revenue

This quarter, Veeva Systems reported year-on-year revenue growth of 14.3%, and its $720.9 million of revenue exceeded Wall Street’s estimates by 3.1%. Company management is currently guiding for a 11.9% year-on-year increase in sales next quarter.

Looking further ahead, sell-side analysts expect revenue to grow 11.4% over the next 12 months, a slight deceleration versus the last three years. Despite the slowdown, this projection is above average for the sector and suggests the market is baking in some success for its newer products and services.

Software is eating the world and there is virtually no industry left that has been untouched by it. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. Click here to access a free report on our 3 favorite stocks to play this generational megatrend.

Customer Acquisition Efficiency

The customer acquisition cost (CAC) payback period measures the months a company needs to recoup the money spent on acquiring a new customer. This metric helps assess how quickly a business can break even on its sales and marketing investments.

Veeva Systems is extremely efficient at acquiring new customers, and its CAC payback period checked in at 17.9 months this quarter. The company’s rapid recovery of its customer acquisition costs means it can attempt to spur growth by increasing its sales and marketing investments. Veeva Systems CAC Payback Period

Key Takeaways from Veeva Systems’s Q4 Results

It was encouraging to see Veeva Systems beat analysts’ revenue and adjusted operating profit expectations this quarter. Looking ahead, while full-year revenue guidance was just in line with Wall Street’s estimates, full-year operating profit guidance was above. Overall, this was a solid quarter. The stock traded up 7.8% to $237 immediately following the results.

Is Veeva Systems an attractive investment opportunity right now? What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here, it’s free.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.